tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (27.27%), 1 are a HOLD (9.09%), 7 are a BUY (63.64%).
Analyst Lyanne Harrison, currently employed at BAML, carries an average stock price target met ratio of 50% that have a potential upside of 15.11% achieved within 140 days.
Lyanne Harrison’s has documented 22 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 26-Sep-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $12.35 (6.42%) receiving and performance score of 21.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Apr-2025
$345
$92.13 (36.43%)
$330
1 months 8 days ago
(02-Feb-2026)
7/9 (77.78%)
$90.85 (35.75%)
59
Hold Since 12-Dec-2024
$265
$12.13 (4.80%)
$260
1 months 8 days ago
(30-Jan-2026)
6/6 (100%)
$7.29 (2.83%)
44
Hold Since 10-Jan-2025
$275
$22.13 (8.75%)
$248
1 months 8 days ago
(30-Jan-2026)
4/4 (100%)
$17.29 (6.71%)
56
Buy Since 13-Apr-2023
$300
$47.13 (18.64%)
$270
4 months 7 days ago
(31-Oct-2025)
15/16 (93.75%)
$54.27 (22.09%)
113
Buy Since 06-Aug-2020
$304
$51.13 (20.22%)
$219
4 months 17 days ago
(21-Oct-2025)
6/7 (85.71%)
$37.03 (13.87%)
75
What Year was the first public recommendation made by Lyanne Harrison?
